The ERN eUROGEN Strategic Board Meeting took place on 26–27 February 2026 at the Radboudumc Experience Center in Nijmegen, Netherlands, in a hybrid format. The meeting brought together 76 participants—34 in person and 42 online—to review progress across all nine work packages and discuss strategic priorities for the remainder of the current grant and beyond.
The meeting demonstrated that ERN eUROGEN is performing well across its work packages, with most planned grant targets on track or exceeded in key areas, including dissemination, webinars, and guideline development. The registry and Clinical Patient Management System (CPMS) remain areas requiring focused effort, and the Board agreed on specific actions to address this.
The report contains a detailed table of consolidated actions with clear ownership and deadlines. All HCPs are encouraged to review their relevant sections and act on assigned items.
Downloads
📄 ERN eUROGEN Strategic Board Meeting 2026: Report (PDF)
Full report including executive summary, consolidated actions, and detailed discussion across all work packages.
📊 ERN eUROGEN Strategic Board Meeting 2026: Compiled Presentations (PDF)
Complete presentation slides delivered during the two-day meeting.
